Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists-Reference-Cited by-同舟云学术

Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists

Published:2010-03 Issue:6 Volume:20 Page:1913-1917
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

He Shuwen,Dobbelaar Peter H.,Liu Jian,Jian Tianying,Sebhat Iyassu K.,Lin Linus S.,Goodman Allan,Guo Cheng,Guzzo Peter R.,Hadden Mark,Henderson Alan J.,Ruenz Megan,Sargent Bruce J.,Yet Larry,Kelly Theresa M.,Palyha Oksana,Kan Yanqing,Pan Jie,Chen Howard,Marsh Donald J.,Shearman Lauren P.,Strack Alison M.,Metzger Joseph M.,Feighner Scott D.,Tan Carina,Howard Andrew D.,Tamvakopoulos Constantin,Peng Qianping,Guan Xiao-Ming,Reitman Marc L.,Patchett Arthur A.,Wyvratt Matthew J.,Nargund Ravi P.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference19 articles.

1. Obesity: Preventing and Managing the Global Epidemic, Report of a WHO Consultation, World Health Organization, Geneva, 2004.

2. Current and Investigational Antiobesity Agents and Obesity Therapeutic Treatment Targets

3. International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States

4. Cloning and expression of the neuromedin B receptor and the third subtype of bombesin receptor genes in the mouse

5. Molecular Basis of the Pharmacological Difference between Rat and Human Bombesin Receptor Subtype-3 (BRS-3)

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Annotated Bibliography of Dr. Arthur A. Patchett;Journal of Medicinal Chemistry;2023-11-30

2. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors;British Journal of Pharmacology;2021-09-16

3. Biaryls;Privileged Structures in Drug Discovery;2018-03-09

4. Imidazole: An Essential Edifice for the Identification of New Lead Compounds and Drug Development;Mini-Reviews in Medicinal Chemistry;2018-01-08

5. Bombesin receptor subtype 3 as a potential target for obesity and diabetes;Expert Opinion on Therapeutic Targets;2015-06-12